Search
Dr. Katrin Rupalla Interviewed by Global Business Reports
- Kellyann Zuzulo
- Apr 26, 2023
- 1 min read
Life Sciences issue 2023 highlights companies making a difference with their research
Read the full interview with Dr. Rupalla in which she discusses Ymmunobio's activities and achievements.
Ymmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...
Michel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...
Ymmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...
Comments